Excited to finally share lab highlights: @CD_AACR tracking metastasis paper last year, more computational work with @siepellab, first PhD graduate @BioPharmDom, @PCFnews Young Investigator Award for Lise, and R01 progress on therapy resistance. More here: https://t.co/tD2FCgloRD
It is never too late to say thanks to the Starr Cancer Consortium for funding our work to determine and target evolutionary trajectories driving #BladderCancer https://t.co/59eEDOHoxL. Glad to work on this project with the labs of @DSolit@MSKCancerCenter and @asiepel@CSHL
A little bit late but huge congratulations to Dom @BioPharmDom and Billy @TheBillyLu for passing their Admission To Doctoral Candidacy Exams! They joined the lab last year as first ever PhD students and are part of PhD Program in Pharmacology @WeillCornell!
.@Nowak_Lab & @trotmanlab: Identification of the phosphatase PHLPP2’s role in controlling MYC stability could have implications for many cancers. JCB’s cancer collection for #AACR20 (https://t.co/hgWqfffjWG) has new short summaries of articles: https://t.co/4RX37rq7jA
The Sheltzer Lab is hiring! Thanks to new funding from
@NYCommTrust, we're looking for a postdoc to work on drug targeting in difficult-to-treat cancers. We're building a highly-collaborative group, and we welcome applicants from all scientific backgrounds.
PHLPP2 promotes prostate cancer progression by @Nowak_Lab@NowakDG@trotmanlab and colleagues https://t.co/ikJTLy8Z3S is part of a special Year in Cell Biology collection for #ASCBEMBO19 https://t.co/jN09f7Sgvp
We are delighted to present the annual Year in Cell Biology collection, highlighting some of the 2019 JCB papers that most captured the attention and interest of JCB readers across the range of cell biology for #ASCBEMBO19 https://t.co/jN09f7Sgvp
The Barbieri Lab is hiring!
Looking for wet-lab and computational post-docs to work on prostate cancer molecular subtypes, transcriptional control, epigenomics, ubiquitin ligases, drug discovery...and anything else we stumble into...
https://t.co/vU58AGn3X1
Please RT!
Today was Matt's last day in the lab so we went to get some ice creams! Matt spent summer with us and did amazing job! A lot of cloning and organoids work with @carolouiseb! He is back to school @OSchoolsPR and hopefully will be back with us next summer!
Toivanen and Furic preview work from @Nowak_Lab and colleagues (https://t.co/iOcaWTJoJw) showing that the phosphatase PHLPP2 controls Myc stability, suggesting a new way to target Myc in #prostate#cancer https://t.co/khc79lgR4D
Researchers at @CSHL and @WeillCornell show in lab-grown cells and mouse models that blocking a protein in human prostate #Cancer cells leads to their death: https://t.co/BEBQbi1cJk
A new JCB study (https://t.co/iOcaWTJoJw) reveals that inhibiting PHLPP2 lowered the levels of MYC, an oncogenic protein that causes many different types of cancer that cannot be targeted by conventional drug therapies. Read the press release: https://t.co/CzhwKY1r2M @Nowak_Lab
Our team is growing! We are looking for a passionate #postdoc to join our team in NYC! Interest in #ProstateCancer, #Metastases and experience with #CancerMetabolism is a big advantage. Please RT! More details here: https://t.co/LfGxtGvS56
Our study shows that PHLPP2 is essential for supporting MYC oncogene. Blocking PHLPP2 prevented progression of #ProstateCancer to #metastasis in our model: https://t.co/A1JzNnjXV6. Great collaboration with @trotmanlab@NewtonLab. Really glad for the support from @WCM_PCa_SPORE !
Really excited about our new study defining the tumor suppressive functions of CHD1 during prostate tumorigenesis. A great example of team science made possible by great mentors and excellent collaborators @Chris_Barbieri1@MarkARubin1@SKCCDirector@PCFnews